151 related articles for article (PubMed ID: 9528894)
1. Serum levels of soluble CD30 are increased in ulcerative colitis (UC) but not in Crohn's disease (CD).
Giacomelli R; Passacantando A; Parzanese I; Vernia P; Klidara N; Cucinelli F; Lattanzio R; Santori E; Cipriani P; Caprilli R; Tonietti G
Clin Exp Immunol; 1998 Mar; 111(3):532-5. PubMed ID: 9528894
[TBL] [Abstract][Full Text] [Related]
2. T-cell activation in Crohn's disease. Increased levels of soluble interleukin-2 receptor in serum and in supernatants of stimulated peripheral blood mononuclear cells.
Mueller C; Knoflach P; Zielinski CC
Gastroenterology; 1990 Mar; 98(3):639-46. PubMed ID: 2298368
[TBL] [Abstract][Full Text] [Related]
3. Peripheral cytokine profile in Chilean patients with Crohn's disease and ulcerative colitis.
Beltrán CJ; Candia E; Erranz B; Figueroa C; Gonzalez MJ; Quera R; Hermoso MA
Eur Cytokine Netw; 2009 Mar; 20(1):33-8. PubMed ID: 19318319
[TBL] [Abstract][Full Text] [Related]
4. Profiles of Lamina Propria T Helper Cell Subsets Discriminate Between Ulcerative Colitis and Crohn's Disease.
Li J; Ueno A; Fort Gasia M; Luider J; Wang T; Hirota C; Jijon HB; Deane M; Tom M; Chan R; Barkema HW; Beck PL; Kaplan GG; Panaccione R; Qian J; Iacucci M; Gui X; Ghosh S
Inflamm Bowel Dis; 2016 Aug; 22(8):1779-92. PubMed ID: 27243594
[TBL] [Abstract][Full Text] [Related]
5. Serum and Mucosal CD30 in Pediatric Inflammatory Bowel Diseases: Useful Biomarker for Diagnosis and Disease Activity Monitoring?
Fabian O; Klocperk A; Lerchova T; Jencova P; Stolova L; Belhajova M; Voriskova D; Kazeka D; Vicha A; Hradsky O; Bronsky J
Dig Dis Sci; 2023 Feb; 68(2):460-470. PubMed ID: 36056999
[TBL] [Abstract][Full Text] [Related]
6. Crossover Subsets of CD4
Li J; Ueno A; Iacucci M; Fort Gasia M; Jijon HB; Panaccione R; Kaplan GG; Beck PL; Luider J; Barkema HW; Qian J; Gui X; Ghosh S
Dig Dis Sci; 2017 Sep; 62(9):2357-2368. PubMed ID: 28573508
[TBL] [Abstract][Full Text] [Related]
7. Altered pattern of tumor necrosis factor-alpha production in peripheral blood monocytes from Crohn's disease.
Loganes C; Pin A; Naviglio S; Girardelli M; Bianco AM; Martelossi S; Tommasini A; Piscianz E
World J Gastroenterol; 2016 Nov; 22(41):9117-9126. PubMed ID: 27895399
[TBL] [Abstract][Full Text] [Related]
8. Evidence for T lymphocyte reactivity to the 65 kilodalton heat shock protein of mycobacterium in active Crohn's disease.
Szewczuk MR; Depew WT
Clin Invest Med; 1992 Dec; 15(6):494-505. PubMed ID: 1286531
[TBL] [Abstract][Full Text] [Related]
9. Distinct patterns of naive, activated and memory T and B cells in blood of patients with ulcerative colitis or Crohn's disease.
Rabe H; Malmquist M; Barkman C; Östman S; Gjertsson I; Saalman R; Wold AE
Clin Exp Immunol; 2019 Jul; 197(1):111-129. PubMed ID: 30883691
[TBL] [Abstract][Full Text] [Related]
10. Increased production of soluble TLR2 by lamina propria mononuclear cells from ulcerative colitis patients.
Candia E; Díaz-Jiménez D; Langjahr P; Núñez LE; de la Fuente M; Farfán N; López-Kostner F; Abedrapo M; Alvarez-Lobos M; Pinedo G; Beltrán CJ; González C; González MJ; Quera R; Hermoso MA
Immunobiology; 2012 Jun; 217(6):634-42. PubMed ID: 22101184
[TBL] [Abstract][Full Text] [Related]
11. Immune system alterations in patients with inflammatory bowel disease during remission.
Sventoraityte J; Zvirbliene A; Kiudelis G; Zalinkevicius R; Zvirbliene A; Praskevicius A; Kupcinskas L; Tamosiūnas V
Medicina (Kaunas); 2008; 44(1):27-33. PubMed ID: 18277086
[TBL] [Abstract][Full Text] [Related]
12. Different production of soluble HLA-G antigens by peripheral blood mononuclear cells in ulcerative colitis and Crohn's disease: a noninvasive diagnostic tool?
Rizzo R; Melchiorri L; Simone L; Stignani M; Marzola A; Gullini S; Baricordi OR
Inflamm Bowel Dis; 2008 Jan; 14(1):100-5. PubMed ID: 17886287
[TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical Assessment of CD30+ Lymphocytes in the Intestinal Mucosa Facilitates Diagnosis of Pediatric Ulcerative Colitis.
Fabian O; Hradsky O; Drskova T; Mikus F; Zamecnik J; Bronsky J
Dig Dis Sci; 2018 Jul; 63(7):1811-1818. PubMed ID: 29541900
[TBL] [Abstract][Full Text] [Related]
14. Differences in the intrinsic capacity of peripheral blood mononuclear cells to produce tumor necrosis factor alpha and beta in patients with inflammatory bowel disease and healthy controls.
Bouma G; Oudkerk Pool M; Scharenberg JG; Kolkman JJ; von Blomberg BM; Scheper RJ; Meuwissen SG; Peña AS
Scand J Gastroenterol; 1995 Nov; 30(11):1095-100. PubMed ID: 8578170
[TBL] [Abstract][Full Text] [Related]
15. CD30-mediated signaling promotes the development of human T helper type 2-like T cells.
Del Prete G; De Carli M; D'Elios MM; Daniel KC; Almerigogna F; Alderson M; Smith CA; Thomas E; Romagnani S
J Exp Med; 1995 Dec; 182(6):1655-61. PubMed ID: 7500010
[TBL] [Abstract][Full Text] [Related]
16. Circulating levels of soluble CD30 are increased in patients with systemic sclerosis (SSc) and correlate with serological and clinical features of the disease.
Giacomelli R; Cipriani P; Lattanzio R; Di Franco M; Locanto M; Parzanese I; Passacantando A; Ciocci A; Tonietti G
Clin Exp Immunol; 1997 Apr; 108(1):42-6. PubMed ID: 9097909
[TBL] [Abstract][Full Text] [Related]
17. Expression of CD30 mRNA, CD30L mRNA and a variant form of CD30 mRNA in restimulated peripheral blood mononuclear cells (PBMC) of patients with helminthic infections resembling a Th2 disease.
Kilwinski J; Berger T; Mpalaskas J; Reuter S; Flick W; Kern P
Clin Exp Immunol; 1999 Jan; 115(1):114-9. PubMed ID: 9933429
[TBL] [Abstract][Full Text] [Related]
18. Retrospective evaluation of the clinical utility of serological biomarkers in Chinese patients with inflammatory bowel disease: 2-year clinical experience.
Zhang S; Luo J; Li J; Wu Z; Hu C; Li P; Deng C; Zhang F; Qian J; Li Y
Clin Chem Lab Med; 2017 May; 55(6):865-875. PubMed ID: 27831916
[TBL] [Abstract][Full Text] [Related]
19. Circulating antiinflammatory cytokine IL-10 in patients with inflammatory bowel disease (IBD).
Kucharzik T; Stoll R; Lügering N; Domschke W
Clin Exp Immunol; 1995 Jun; 100(3):452-6. PubMed ID: 7774055
[TBL] [Abstract][Full Text] [Related]
20. In vivo CD30 expression in human diseases with predominant activation of Th2-like T cells.
D'Elios MM; Romagnani P; Scaletti C; Annunziato F; Manghetti M; Mavilia C; Parronchi P; Pupilli C; Pizzolo G; Maggi E; Del Prete GF; Romagnani S
J Leukoc Biol; 1997 May; 61(5):539-44. PubMed ID: 9129201
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
